Pharmaceuticals News and Research

RSS
Emergent BioSolutions completes Trubion acquisition

Emergent BioSolutions completes Trubion acquisition

29 Oct 2010
Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

29 Oct 2010
Latuda tablets receive FDA approval for treatment of adults with schizophrenia

Latuda tablets receive FDA approval for treatment of adults with schizophrenia

29 Oct 2010
Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

29 Oct 2010
Metagenics awarded two new patents for hops-derived anti-inflammatory compositions

Metagenics awarded two new patents for hops-derived anti-inflammatory compositions

28 Oct 2010
Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

28 Oct 2010
Malvern Zetasizer Nano used to characterize environmentally responsive nanoparticles

Malvern Zetasizer Nano used to characterize environmentally responsive nanoparticles

From Malvern Panalytical 28 Oct 2010
Bioniche ranked #14 on Top 50 Best Small and Medium Employers in Canada

Bioniche ranked #14 on Top 50 Best Small and Medium Employers in Canada

28 Oct 2010
Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia

Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia

28 Oct 2010
POZEN reports net loss of $8.6M for third quarter 2010 vs. net income of $6.7M for third quarter 2009

POZEN reports net loss of $8.6M for third quarter 2010 vs. net income of $6.7M for third quarter 2009

28 Oct 2010
Celgene third quarter non-GAAP total revenue increases 31% to $908 million

Celgene third quarter non-GAAP total revenue increases 31% to $908 million

28 Oct 2010
Omnicare third quarter net sales increases from $1,543.9 million to $1,544.4 million

Omnicare third quarter net sales increases from $1,543.9 million to $1,544.4 million

28 Oct 2010
CCS presents new 2010 Atrial Fibrillation Guidelines

CCS presents new 2010 Atrial Fibrillation Guidelines

28 Oct 2010
BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

28 Oct 2010
UNC awards Doctorate degree to Premier Research biostatistician

UNC awards Doctorate degree to Premier Research biostatistician

28 Oct 2010
Outcomes detects over one million drug therapy problems through Targeted Intervention Program

Outcomes detects over one million drug therapy problems through Targeted Intervention Program

28 Oct 2010
AstraZeneca 2010 third quarter decreases 2% to $7,898 million

AstraZeneca 2010 third quarter decreases 2% to $7,898 million

28 Oct 2010
Abbott provides $180,000 to support recent cholera outbreak in central Haiti

Abbott provides $180,000 to support recent cholera outbreak in central Haiti

28 Oct 2010
AnaptysBio announces issuance of two new patents for SHM-XEL platform

AnaptysBio announces issuance of two new patents for SHM-XEL platform

28 Oct 2010
The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

28 Oct 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback